Natalie Sacks, Chief Medical Officer at Harpoon Therapeutics, Inc. (HARP), sold 1,270 shares at $12.00 ($15K) on 2020-04-06, disclosed to the SEC on 2020-04-08.
Scheduled sale ($15k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.00 | 700 | $8K | 55.1% |
| 2 | $12.00 | 570 | $7K | 44.9% |
| Total | $12.00 avg | 1,270 | $15K | 100% |
| Filing → |
| HARP | SELL | 2020-04-17 | $18K | — | Filing → |
| HARP | SELL | 2020-04-15 | $110K | — | Filing → |
| HARP | SELL | 2020-03-18 | $18K | — | Filing → |